SBIR-STTR Award

Miniature, Modular, Multiparameter Flow Cytometer to Facilitate Drug Evaluations
Award last edited on: 11/11/2002

Sponsored Program
SBIR
Awarding Agency
DOE
Total Award Amount
$849,784
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Martin Casstevens

Company Information

Advanced Cytometry Instrumentation Systems

Baird Research Park 1576 Sweet Home Road
Amherst, NY 14228
   (716) 689-9797
   information@acisflowcyte.com
   www.acisflowcyte.com
Location: Single
Congr. District: 26
County: Erie

Phase I

Contract Number: DE-FG02-01ER83134
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2001
Phase I Amount
$99,784
Instrumentation is needed that can rapidly analyze the interactions between living cells and candidate therapeutic agents. This project will develop a miniature, high performance flow cytometer, equipped with recent advances in lasers, optics, and detectors. The cytometer will rapidly evaluate many parameters one cell at a time, use very small samples sizes, avoid aggregate responses, and permit the cells to be later sorted. Modulation techniques coupled with mathematical analyses will be used to distinguish between signals arising from different laser sources. In Phase I, a solid state laser, advanced optics, and recently developed detectors will be incorporated into the system. A detection system will be developed that involves fewer optical elements than conventional cytometry units and uses modulation techniques to further enhance performance. The system will be tested with live cells.

Commercial Applications and Other Benefits as described by the awardee:
The technology should allow flow cytometers to be used for recently developed methods such as combinatorial chemistry. In addition to applications in drug discovery, flow cytometers should find new applications in medical research, clinical practice, environmental analyses, etc.

Phase II

Contract Number: N/A
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2002
Phase II Amount
$750,000
___(NOTE: Note: no official Abstract exists of this Phase II projects. Abstract is modified by idi from relevant Phase I data. The specific Phase II work statement and objectives may differ)___ Instrumentation is needed that can rapidly analyze the interactions between living cells and candidate therapeutic agents. This project will develop a miniature, high performance flow cytometer, equipped with recent advances in lasers, optics, and detectors. The cytometer will rapidly evaluate many parameters one cell at a time, use very small samples sizes, avoid aggregate responses, and permit the cells to be later sorted. Modulation techniques coupled with mathematical analyses will be used to distinguish between signals arising from different laser sources. In Phase I, a solid state laser, advanced optics, and recently developed detectors will be incorporated into the system. A detection system will be developed that involves fewer optical elements than conventional cytometry units and uses modulation techniques to further enhance performance. The system will be tested with live cells.

Commercial Applications and Other Benefits as described by the awardee:
The technology should allow flow cytometers to be used for recently developed methods such as combinatorial chemistry. In addition to applications in drug discovery, flow cytometers should find new applications in medical research, clinical practice, environmental analyses, etc.